These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 24600767)
1. Role of topical drugs in treatment of oral mucosal diseases. A literature review. Sheikh S; Gupta D; Pallagatti S; Singla I; Gupta R; Goel V N Y State Dent J; 2013 Nov; 79(6):58-64. PubMed ID: 24600767 [TBL] [Abstract][Full Text] [Related]
2. Local drug delivery for oral mucosal diseases: challenges and opportunities. Sankar V; Hearnden V; Hull K; Juras DV; Greenberg MS; Kerr AR; Lockhart PB; Patton LL; Porter S; Thornhill M Oral Dis; 2011 Apr; 17 Suppl 1():73-84. PubMed ID: 21382140 [TBL] [Abstract][Full Text] [Related]
3. Inflammatory diseases of the mucous membranes. Part 2. Immunopathologic ulcerative and desquamative diseases. Eversole LR J Calif Dent Assoc; 1994 Apr; 22(4):59-60, 64, 6809 passim. PubMed ID: 8598527 [TBL] [Abstract][Full Text] [Related]
4. Strategies for management of commonly encountered oral mucosal disorders. Siegel MA J Calif Dent Assoc; 1999 Mar; 27(3):210-2, 215, 218-9 passim. PubMed ID: 10634127 [TBL] [Abstract][Full Text] [Related]
5. Oral mucosal diseases in the office setting--Part II: oral lichen planus, pemphigus vulgaris, and mucosal pemphigoid. Sciubba JJ Gen Dent; 2007; 55(5):464-76; quiz 477-8, 488. PubMed ID: 17899727 [TBL] [Abstract][Full Text] [Related]
6. Further reliability and responsiveness of the Chronic Oral Mucosal Diseases Questionnaire. Ni Riordain R; McCreary C Oral Dis; 2012 Jan; 18(1):60-6. PubMed ID: 22117794 [TBL] [Abstract][Full Text] [Related]
8. The Pharmacologic Management of Common Lesions of the Oral Cavity. Radulescu M Dent Clin North Am; 2016 Apr; 60(2):407-20. PubMed ID: 27040292 [TBL] [Abstract][Full Text] [Related]
9. Oral mucosal diseases: evaluation and management. Stoopler ET; Sollecito TP Med Clin North Am; 2014 Nov; 98(6):1323-52. PubMed ID: 25443679 [TBL] [Abstract][Full Text] [Related]
10. Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents. Elad S; Epstein JB; von Bültzingslöwen I; Drucker S; Tzach R; Yarom N Expert Opin Emerg Drugs; 2011 Mar; 16(1):183-202. PubMed ID: 21244328 [TBL] [Abstract][Full Text] [Related]
11. Biologic agents and oral diseases -- an update on clinical applications. Georgakopoulou EA; Andreadis D; Arvanitidis E; Loumou P Acta Dermatovenerol Croat; 2013; 21(1):24-34. PubMed ID: 23683483 [TBL] [Abstract][Full Text] [Related]
15. Off-label use of biologicals in the management of inflammatory oral mucosal disease. O'Neill ID J Oral Pathol Med; 2008 Nov; 37(10):575-81. PubMed ID: 18764859 [TBL] [Abstract][Full Text] [Related]
17. The patient with recurrent oral ulceration. Talacko AA; Gordon AK; Aldred MJ Aust Dent J; 2010 Jun; 55 Suppl 1():14-22. PubMed ID: 20553241 [TBL] [Abstract][Full Text] [Related]
18. [Vesiculobullous lesions of the oral mucosa]. Spijkervet FK; Vissink A; Raghoebar GM; van der Waal I Ned Tijdschr Tandheelkd; 2001 Jun; 108(6):223-8. PubMed ID: 11441714 [TBL] [Abstract][Full Text] [Related]
19. [A study of therapeutic efficacy of Koukangning gargle in the treatment of oral mucositis]. Zeng G; Li B; Zhang W Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 Feb; 15(1):28-30, 54. PubMed ID: 11480052 [TBL] [Abstract][Full Text] [Related]